Bank Julius Baer & Co’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Bank Julius Baer & Co's DGX Position: Q3 2025 in Review
Bank Julius Baer & Co sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 393 shares — an estimated $70.6K sold.
Bank Julius Baer & Co first reported a position in DGX in Q1 2020 and held it in 16 quarters. The position peaked at $384K in Q1 2021. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.
- Bank Julius Baer & Co reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
- Bank Julius Baer & Co sold 393 Quest Diagnostics shares in Q3 2025, an estimated $70.6K.
- Bank Julius Baer & Co first reported a position in Quest Diagnostics in Q1 2020 and held it in 16 quarters.
- Bank Julius Baer & Co's Quest Diagnostics position peaked at $384K in Q1 2021.
- 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.
Based on Bank Julius Baer & Co's 13F filing for Q3 2025, filed 13 Nov 2025.